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Cardiac Resynchronization Therapy (CRT), realised using 
biventricular pacemaker is used to treat patients with in 
systolic heart failure (HF) and with prolonged QRS. The 
goal of CRT is to eliminate or reduce the 
electromechanical dyssynchrony processes often 
responsible of cardiac remodelling. The aim of this work 
is to study the effects of CRT on the energetic left 
ventricular variables as external work, the pressure-
volume area and the potential energy. In order to study the 
effects produced by CRT on energetic left ventricular 
balance it was used the numerical model of the 
cardiovascular system (CARDIOSIM©), able to reproduce 
the effects induced by biventricular pacemaker (BPM).   
Starting from literature data, the haemodynamic 
conditions of a group of patients,  representative of the 
most common disease etiologies of heart failure, were 
simulated before and after CRT treatment.   
The trend of the energetic left ventricular variables was 
studied for each patient in order to evaluate the effects 
produced by the CRT.  
The obtained results shown that the software simulator 
can predict the dynamics of energetic left ventricular 
balance in patients affected by HF and treated with 
cardiac resynchronization therapy. 
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The Cardiac Resynchronization Therapy (CRT) was 
proposed in the mid 90s as a possible treatment for 
patients with end-stage heart failure (HF). In this 
pathological condition the left ventricle mechanics is 
depressed, uncoordinated and it presents a prolonged QRS 
time duration.  
The following guidelines indications for CRT are 
proposed by ACC / AHA / NASPE (CRT, 2002) [1], by 
the ESC (failure chronic heart, 2005) [2] and ACC / AHA 
(failure chronic heart, 2005) [3]: 
• The CRT is indicated for patients in sinus rhythm with 
advanced heart failure (NYHA class III-IV), left 
ventricular systolic dysfunction (ejection fraction EF ≤ 
35%) LV telediastolic diameter ≥ 55 mm and QRS 
duration ≥ 130 ms (IIA) [1]. 
• The CRT can be applied in patients with reduced 
ejection fraction and ventricular dyssynchrony (QRS 
duration ≥ 120 ms) who remain symptomatic (NYHA III-
IV) after medical therapy induced to improve the 
symptoms (IA), reduce hospitalizations (IA) and mortality 
(IB) [2] 
• The CRT should be considered in patients with EF ≤ 
35%, sinus rhythm, NYHA functional class III-IV and 
ventricular dyssynchrony (QRS ≥ 120 ms) [3]. 
The goal of CRT is to eliminate or reduce the 
electromechanical dyssynchrony processes often 
responsible of cardiac remodelling. 
The aim of this work was to study the effects of CRT on 
the energetic left ventricular variables as external 
mechanical work (EW), the pressure-volume area (PVA) 
and the elastic potential energy (PE) [4,5]. These 
variables describe from energetic point of view the 
energetic balance of the ventricle. In order to study the 
ventricular energetic balance before and during CRT 
treatment it was used the numerical simulator of the 
cardiovascular system (CARDIOSIM©) [6,7]. In this 
software simulator the atrio-ventricular activity is related 
to ECG signal. The cardiovascular simulator is also able 
to reproduce the interventricular and/or intraventricular 
dyssynchrony. The ventricular interaction (or “ventricular 
interdependence”) is implemented through the 
interventricular septum [4,8]. The concept of “ventricular 
interdependence” considers the properties of one ventricle 
to be a function of the properties of the contralateral 
ventricle. 
Starting from literature data [9], the haemodynamic 
conditions of a group of patients,  were simulated before 
and within seven days and within six months since CRT 
treatment.  In order to place on the pressure-volume plane 
the left ventricular cardiac loop, the literature data [9] 
were used to set the software parameters to reproduce the 
end-systolic and end-diastolic left ventricular volume and 
the mean (AoP) aortic pressure. In this way, for each 
patient, the simulator can calculate and predict the trend 
of the EW, the PVA and the PE.  
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2. Materials and Methods 
 
2.1 Numerical simulator 
 
The software simulator of the cardiovascular system 
CARDIOSIM(C) [6,7] is able to reproduce, by 
haemodynamic point of view, physiopathological 
circulatory phenomena. The simulator has a modular 
structure that includes (Figure 1): the systemic 
(pulmonary) arterial section modelled by a modified 
windkessel with a characteristic resistance Rcs (Rcp), a 
inertance Ls (Lp), a compliance Cas (Cap) and a variable 
peripheral resistance Ras (Rap); the systemic venous 
section modelled by a compliance Cvs and the variable 
resistance Rvs [10]; the pulmonary venous section 
modelled by a simple compliance Cvp [10]; the coronary 
section [7];the left and the right heart. 
Heart valves are modelled using a diode with a series 
resistance (Figure 1) assuming the unidirectional way of 
the blood flow. 
The behaviour of both atria is described by variable 
elastance models and their mechanical properties are 
related to ECG signal [9,11]. Also ventricles are described 
by variable elastance models reproducing the Starling’s 
law of the heart [4,8,11].  
The left time-varying ventricular elastance elv(t) is 
described as a function of the left ventricular systolic 
elastance Elvs, the left ventricular diastolic elastance Elvd 
and the left activation function alv(t): 
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Figure 1. Electric analogue of the cardiovascular system
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T is the duration of the ECG signal (heart period), TTE is 
the end of ventricular systole  and TT is the T-wave peak 
time. 
The instantaneous left ventricular pressure is described 
by: 
 
 ( )( ) ( ) ( ( ) ) ( )
( )
Plv tPlv t elv t Vlv t Vlo Vlv t Vlo
elv t
⎛ ⎞= ⋅ − ⇒ = +⎜ ⎟⎝ ⎠    (3) 
 
Vlo is the rest volume of the left ventricle and Vlv(t) 
(Plv(t)) is the instantaneous left ventricular volume 
(pressure). 
In order to simulate the intra-ventricular dyssynchrony a 
model of the ventricular interaction is implemented 
through the inter-ventricular behaviour of the septum 
[4,8]. Using a time-varying elastance model to reproduce 
the behaviour of the septum, it is possible describes the 
instantaneous left (right) ventricular pressure as fellow: 
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eSPT(t) is the time-varying septum elastance, erv(t) is the 
right time-varying ventricular elastance, Vrv(t) (Prv(t)) is 
the instantaneous right ventricular volume (pressure) and 
Vro is the rest volume of the right ventricle. 
In this way the pressure of the left (right) ventricular 
chamber is described as a function of its elastance, of the 
pressure and the elastance of the right (left) ventricular 
chamber. 
  
2.2 Energetic left ventricular variables 
 
In the pressure-volume plane the left ventricular loop is 
represented as in Figure 2. 
The total external mechanical work (EW) represents the 
area within the pressure-volume loop. PE is the elastic 
potential energy stored in the ventricular wall at end 
systole. The pressure volume area (PVA) consists of EW 
performed during systole and PE presumed to be stored in 
the myocardium at end systole [4,5].   
 
2.3 Experimental setup 
 
Staring from literature data [9], the conditions of the 
patients were reproduced by setting model parameters as 
reported below: 
• in order to obtain the measured systolic (BPS) and 
diastolic (BPD) systemic arterial pressure [9], the 
peripheral resistance was automatically calculated; 
• starting from Ras, BPS, BPD and the time constant, the 
aortic compliance was estimated; 
• left ventricular systolic (diastolic) elastance was set in 
order to place the left ventricular loop in the pressure-
volume plane, knowing the measured end systolic volume 
(ESV) and end diastolic volume (EDV). To place the left 
ventricular loop, it has also been assumed that the left 
ventricular end systolic pressure (Pes) can be 























• septum systolic (diastolic) elastance was calculated 
starting from systolic (diastolic) septum thickness [9]; 
• heart rate (HR), QT, PQ, and QRS times were set as the 
measured value [9];  
• inter-ventricular and intra-ventricular delay were set as 
the data measured [9]. 
Table 1 shows the data used to set the software simulator 
in order to reproduce the patient conditions before, within 




Table 2 shows the results obtained by software simulator 
before, within 7 days and within 6 months CRT treatment. 
From Suga and Sagawa studies [4,5] it is possible to 
define the external work as: 
 
   EW=Pes·(EDV-ESV)    (5) 
 
where Pes can be approximated with the mean aortic 
pressure [4,5]. 
Starting from this approximation it is possible estimate 
the EW value from the data reported in Table 1. Figure 3 
shows the trend of the normalized EW evaluated in 
patients before CRT treatment. In the chart the 
“calculated” EW values were obtained as previously 
described using the data presented in Table 1. 
(4)
Figure 2.  Schematic representation of the cardiac loop on the 
pressure-volume plane. ESPVR is the End Systolic Pressure 
Volume Relationship line. Pes (ESV) is the left ventricular end 
systolic pressure (volume). Vo and EDV are respectively the rest 
volume the end diastolic volume.   
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ESV EDV EW PE PVA
[ml] [ml] [Joule/beat] [Joule/beat] [Joule/beat]
#1 90,7 58,3 190,58 213,217 0,062 0,549 0,611
#2 112 59 139,43 200,53 0,847 0,718 1,565
#3 110 71,7 104,2 159,63 0,648 0,52 1,168
#4 130,5 88 110,37 170,84 0,94 0,708 1,648
#5 99 72,2 78,59 106,11 0,225 0,342 0,567
#6 109,7 79,3 115,28 162.5 0,374 0,548 0,922
#7 100.4 62,8 144,19 186,08 0,214 0,459 0,673
#1 92,8 62 164,31 205,57 0,394 0,732 1,126
#2 101,5 61,5 152,36 225,85 0,949 0,729 1,678
#3 101 61,8 95,95 162,96 0,645 0,4 1,045
#4 119,2 81,9 93,98 151,55 0,744 0,538 1,282
#5 101,9 61,7 51,42 80,88 0,208 0,188 0,396
#6 121,2 76,4 103.13 152.85 0,436 0,372 0,808
#7 102,2 64,4 127,05 177,27 0,47 0,54 1,01
#1 91,4 60,9 129,96 171,20 0,374 0,566 0,94
#2 109,6 69,7 144,29 216,22 0,772 0,726 1,498
#3 101,4 61.6 85,90 153,3 0,66 0,357 1,017
#4 110 71,8 90,10 151,7 0,721 0,469 1,19
#5 102 61 45,97 85,15 0,393 0,19 0,583
#6 125,8 72,8 94.11 152.72 0,602 0,468 1,070






Within 7 days since CRT




The simulated EW values were calculated by the 
simulator as the area within the pressure-volume loop. 
Figure 4 an 5 show the normalized EW in patients 
Table 2. Simulated data. 
Figure 3. EW evaluated in patients before CRT treatment. 
Comparison between data obtained starting from Table 1 

















Table 1. Data used to set the software simulator in order to reproduce the patient conditions before CRT 
respectively, within 7 days and within 6 months. (FA indicates atrial fibrillation). 













Delay  [ms]  
Intra-ventricular 







#1 76 90 60 70 192 (213) 20 70 180 340 180 
#2 75 110 60 77 139 (201) 28 50 140 420 220 
#3 68 110 70 83 105 (160) 50 60 150 410 180 
#4 80 130 85 100 110 (170) 45 60 150 420 FA 
#5 70 100 70 80 78 (105) 37 67 120 400 180 
#6 64 110 80 90 115(160) 30 50 140 410 160 
#7 65 100 60 73 144 (186) 37 50 140 400 160 
 Within 7 days since CRT 
#1 75 94 62 73 167 (204) 20 25 120 370 160 
#2 75 100 60 73 153 (225) 3 20 180 400 200 
#3 66 100 60 73 95 (160) 25  25 130 420 180 
#4 75 120 80 93 94 (150) 30 20 130 420 FA 
#5 70 100 60 73 52 (80) 10 12 120 400 180 
#6 68 123 75 91 105 (155) 14 20 130 400 160 
#7 70 105 60 75 127 (177) 20 32 130 410 160 
 Within 6 months since CRT 
#1 75 95 60 72 130 (169) 20 20 120 370 160 
#2 75 110 70 83 145 (215) 10 20 160 420 180 
#3 64 100 60 73 86 (153) 20 25 140 420 180 
#4 70 110 70 83 90 (150) 25 20 130 430 FA 
#5 80 100 60 73 46 (85) 0 6 120 420 180 
#6 70 120 75 90 94 (154) 9 20 130 410 160 
#7 70 110 70 83 120 (171) 9 20 130 410 160 
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In order to evaluate the evolution of EW, PE and PVA 
before CRT, within 7 days since CRT and within 6 
months since CRT [12], for each patient, different 
simulations were done using as input parameters of the 
software the data reported in Table 1. Results, reported in 
Table 2, have been normalized and are shown in Figure 6, 





The data presented showed that the software simulator of 
the cardiovascular system, permits to reproduce the 
haemodynamic parameters in different cardiocirculatory 
conditions. By comparing the simulated data BPS, BPD, 
ESV and EDV (Table 2) with the corresponding measured 
data (Table 1), it is possible to observe as the software 
simulator can reproduce the patient conditions in different 
situations. Finally Figure 3,4 and 5 show as calculated 
EW data (in approximated way) can be compared with the 
corresponding data elaborated by the simulator. 
The study suggests that tracking of the energetic balance 
of the left ventricle and its optimization might be 
important for the management of the cardiac 
resynchronization therapy [13,14]. 
 
Figure 5. EW evaluated in patients within 6 months since 
CRT treatment. Comparison between data obtained starting 

















Figure 4. EW evaluated in patients within 7 days since CRT 
treatment. Comparison between data obtained starting from 

















Figure 6. Normalized EW evolution before CRT, within 7 







#1 #2 #3 #4 #5 #6 #7
Normalized EW
Before CRT Within 7 days since CRT Within 6 months  since CRT
Figure 8. Normalized PVA evolution before CRT, within 7 







#1 #2 #3 #4 #5 #6 #7
Normalized PVA
Before CRT Within 7 days since CRT Within 6 months  since CRT
Figure 7. Normalized PE evolution before CRT, within 7 
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